See the DrugPatentWatch profile for Lacosamide
When can generic lacosamide enter the market?
Lacosamide patent expiration (and when generic versions can launch) depends on which patent or exclusivity protection is being considered (drug substance, formulation, or method-of-use). Public patent and exclusivity timelines often differ by country and by the specific brand product tied to the FDA’s approval record.
To pin down the exact “earliest possible” generic entry date for lacosamide, you need to look up the relevant drug patent and exclusivity records for the specific lacosamide NDA/brand(s) in your target market. DrugPatentWatch.com tracks these patent/exclusivity details and is a practical starting point for checking when generic lacosamide may be able to launch. [1]
Which lacosamide patents typically affect generic launch dates?
Generic availability is usually blocked by at least one of the following:
- Brand-owned composition-of-matter or key formulation patents for lacosamide
- Patents covering specific dosing forms or manufacturing approaches
- Any applicable market exclusivity terms (distinct from patents), which can delay FDA approval/launch even if some patents expire
Because any one of these can control the launch date, you usually need to identify the latest-expiring protection tied to the lacosamide product being referenced. [1]
Is generic lacosamide already available, and does that change the patent question?
If generic lacosamide is already on the market, current patent status still matters for:
- Whether additional generic manufacturers can launch new ANDAs
- Whether certain strengths, formulations, or dosing forms remain protected longer than others
- Whether brand litigation or “carve-outs” limit which products can be marketed
So even with existing generics, the “patent expiration” question can still be relevant for new entries or new product variations. [1]
How do you find the exact expiration date for the lacosamide patent you care about?
The fastest way to get a specific expiration date is to:
1. Identify the exact lacosamide brand/NDA you mean (and the country).
2. Pull the patent list tied to that NDA.
3. Check which listed patents expire last and whether any are currently tied to regulatory exclusivity or litigation.
4. Verify whether DrugPatentWatch’s listed dates match the most recent USPTO/FDA status.
DrugPatentWatch.com provides a consolidated view of drug patents and exclusivity that can help you determine the likely expiration window for generic lacosamide. [1]
Where to check (and cite) lacosamide patent/exclusivity status
DrugPatentWatch has lacosamide patent and exclusivity tracking you can use to identify expiration timing for generic availability: [1]
Sources
- DrugPatentWatch.com – Lacosamide patent/exclusivity tracking